Conclusions. A CART regimen of SQ-RT-AT alone demonstrated sustained irologic efficacy and was associated with significant increases in the CD4+ lymphocyte count.

• 结论：SQ-RT-AT的CART配方独自显示出抗病毒效应，这也和CD4+淋巴细胞计数的明显升高有关。